Pulmonx Corp (LUNG) Stock Price, Quote & News

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 364 0400

Website: pulmonx.com

Address:

700 Chesapeake Drive, Redwood City, United States

beachsidefreddy Jul. 14 at 6:10 PM

$LUNG there’s a very good reason the shorts cut their position in half from two weeks ago this was just reported this past Friday at 4 o’clock

0 · Reply

beachsidefreddy Jul. 14 at 2:56 PM

$LUNG someone thinks with a pretty big bet for this stock that this Friday it’s gonna be over $2.50

0 · Reply

Layne_Thomas_Staley Jul. 13 at 4:14 PM

$LUNG $

1 · Reply

beachsidefreddy Jul. 13 at 3:59 PM

$LUNG AERISEAL OR TAKEOVER COMING

0 · Reply

beachsidefreddy Jul. 13 at 3:02 PM

$LUNG SHORTS COVERED 1.2 MILLION SHARES IN LAST READ FROM NAZ!!

1 · Reply

beachsidefreddy Jul. 9 at 10:08 PM

$LUNG on the 17th expiration there is a big OI on $2.50 calls

2 · Reply

beachsidefreddy Jul. 9 at 4:17 PM

$LUNG let the games begin

0 · Reply

beachsidefreddy Jul. 9 at 1:38 PM

$LUNG either one of two things are gonna happen shortly either AERISEAL or takeover

0 · Reply

beachsidefreddy Jul. 9 at 11:30 AM

$LUNG shorts returned highest number yet AERISEAL COMING VERY SOON

0 · Reply

beachsidefreddy Jul. 8 at 2:26 PM

$LUNG all this bullshit for the last half hour was to get that huge bid filled at 1:48

0 · Reply

Pulmonx Transcript: AGM 2026

Jun 1, 2026, 4:05 PM EDT - 6 weeks ago

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 12, 2026, 11:15 AM EDT - 2 months ago

Pulmonx Transcript: Bank of America Global Healthcare Conference 2026

2026-04-29T20:32:57.000Z - 2 months ago

Pulmonx reports Q1 EPS (33c), consensus (33c)

2026-04-29T20:30:26.000Z - 2 months ago

Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.87M

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Earnings release: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Quarterly report: Q1 2026

Apr 29, 2026, 4:05 PM EDT - 2 months ago

Pulmonx Reports First Quarter 2026 Financial Results

Apr 28, 2026, 4:05 PM EDT - 2 months ago

Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Pulmonx Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Pulmonx Proxy statement: Proxy filing

Apr 15, 2026, 4:05 PM EDT - 3 months ago

Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

2026-03-05T11:42:24.000Z - 4 months ago

Pulmonx price target lowered to $5 from $6 at Canaccord

2026-03-04T21:39:51.000Z - 4 months ago

Pulmonx reports Q4 EPS (25c), consensus (38c)

2026-03-04T21:38:59.000Z - 4 months ago

Pulmonx sees FY26 revenue $90M-$92M, consensus $94.23M

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Earnings release: Q4 2025

Mar 4, 2026, 4:06 PM EST - 4 months ago

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 4, 2026, 4:05 PM EST - 4 months ago

Pulmonx Announces Closing of up to $60 Million Credit Facility

Mar 4, 2026, 7:00 AM EST - 4 months ago

Pulmonx Slides: Investor presentation

Feb 20, 2026, 8:00 AM EST - 5 months ago

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Dec 3, 2025, 4:05 PM EST - 7 months ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Nov 24, 2025, 7:00 AM EST - 8 months ago

Pulmonx Registration statement: Registration Filing

2025-11-12T21:50:46.000Z - 8 months ago

Pulmonx reports Q3 EPS (34c), consensus (42c)

2025-11-12T21:50:40.000Z - 8 months ago

Pulmonx cuts FY25 revenue view to $89M-$90M from $90M-$92M

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Earnings release: Q3 2025

Nov 12, 2025, 4:05 PM EST - 8 months ago

Pulmonx Reports Third Quarter 2025 Financial Results

2025-10-28T12:45:40.000Z - 9 months ago

Pulmonx price target lowered to $4 from $8 at Lake Street

2025-10-27T20:16:44.000Z - 9 months ago

Pulmonx CEO Steve Williamson resigns, Glen French succeeds

2025-10-27T20:16:21.000Z - 9 months ago

Pulmonx reports preliminary Q3 revenue $21.5M, consensus $20.78M

Oct 27, 2025, 4:05 PM EDT - 9 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Oct 15, 2025, 4:05 PM EDT - 9 months ago

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

2025-09-26T21:25:28.000Z - 10 months ago

Pulmonx files $200M mixed securities shelf

Sep 26, 2025, 8:00 AM EDT - 10 months ago

Pulmonx Registration statement: Registration Filing

Sep 4, 2025, 4:30 PM EDT - 11 months ago

Pulmonx Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 26, 2025, 4:05 PM EDT - 11 months ago

Pulmonx to Participate in September Investor Conferences

Aug 12, 2025, 10:00 AM EDT - 1 year ago

Pulmonx Transcript: Canaccord Genuity’s 45th Annual Growth Conference

2025-07-31T13:07:02.000Z - 1 year ago

Pulmonx price target lowered to $8 from $12 at Lake Street

2025-07-31T09:10:37.000Z - 1 year ago

Pulmonx downgraded to Neutral from Overweight at Piper Sandler

Jul 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Quarterly report: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings release: Q2 2025

2025-07-30T20:17:04.000Z - 1 year ago

Pulmonx reports Q2 EPS (38c), consensus (40c)

2025-07-30T20:15:53.000Z - 1 year ago

Pulmonx cuts FY25 revenue view to $90M-$92M from $96M-$98M, consensus $96.95M

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Jun 11, 2025, 10:00 AM EDT - 1 year ago

Pulmonx Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

2025-05-22T10:41:01.000Z - 1 year ago

Pulmonx price target lowered to $4.15 from $6.50 at Citi

May 14, 2025, 12:35 PM EDT - 1 year ago

Pulmonx Transcript: Bank of America 2025 Healthcare Conference

May 1, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

2025-05-01T11:03:30.000Z - 1 year ago

Pulmonx price target lowered to $9 from $10 at Piper Sandler

2025-05-01T10:56:40.000Z - 1 year ago

Pulmonx price target lowered to $15 from $16 at Canaccord

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings release: Q1 2025

2025-04-30T20:21:35.000Z - 1 year ago

Pulmonx reports Q1 EPS (36c), consensus (40c)

2025-04-30T20:20:42.000Z - 1 year ago

Pulmonx backs FY25 revenue view $96M-$98M, consensus $96.98M

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2025 Financial Results

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Pulmonx Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Pulmonx Proxy statement: Proxy Filing

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

Feb 27, 2025, 11:00 AM EST - 1 year ago

Pulmonx Transcript: Citi’s 2025 Medtech and Life Sciences Access Day

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Earnings Call Transcript: Q4 2024

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Annual report: Q4 2024

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Earnings release: Q4 2024

Feb 19, 2025, 4:05 PM EST - 1 year ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 19, 2025, 7:00 AM EST - 1 year ago

Pulmonx Slides: Investor Presentation

Feb 13, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 5, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Dec 4, 2024, 12:30 PM EST - 1 year ago

Pulmonx Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 9:10 AM EST - 1 year ago

Pulmonx Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 9:00 AM EST - 1 year ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 5, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Quarterly report: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings release: Q3 2024

Oct 16, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Sep 9, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 5, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Transcript: 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 22, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q2 2024

Jul 31, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q1 2024

May 1, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports First Quarter 2024 Financial Results

Apr 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 2, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Feb 26, 2024, 8:00 AM EST - 2 years ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Earnings Call Transcript: Q4 2023

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Annual report: Q4 2023

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Earnings release: Q4 2023

Feb 21, 2024, 4:06 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:05 PM EST - 2 years ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 7, 2024, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Nov 29, 2023, 2:00 PM EST - 2 years ago

Pulmonx Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q3 2023

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q3 2023

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q3 2023

Oct 30, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 30, 2023, 3:30 PM EDT - 2 years ago

Pulmonx Slides: Investor Presentation

Oct 16, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 10, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Sep 6, 2023, 2:15 PM EDT - 3 years ago

Pulmonx Transcript: Wells Fargo Securities Healthcare Conference 2023

Aug 2, 2023, 8:00 PM EDT - 3 years ago

Pulmonx Slides: Investor Presentation

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q2 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Quarterly report: Q2 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings release: Q2 2023

Aug 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 17, 2023, 8:00 AM EDT - 3 years ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

May 9, 2023, 6:55 PM EDT - 3 years ago

Pulmonx Transcript: Bank of America Global Healthcare Conference 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q1 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Quarterly report: Q1 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings release: Q1 2023

May 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports First Quarter 2023 Financial Results

May 1, 2023, 5:00 AM EDT - 3 years ago

Pulmonx Slides: Investor Presentation

Apr 25, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Apr 18, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Apr 4, 2023, 8:00 AM EDT - 3 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 4, 2023, 8:00 AM EDT - 3 years ago

Pulmonx Proxy statement: Proxy Filing

Mar 2, 2023, 3:30 PM EST - 3 years ago

Pulmonx Transcript: Citi Healthcare & Medtech Conference

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Earnings Call Transcript: Q4 2022

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Annual report: Q4 2022

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Earnings release: Q4 2022

Feb 22, 2023, 4:05 PM EST - 3 years ago

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

beachsidefreddy Jul. 14 at 6:10 PM

$LUNG there’s a very good reason the shorts cut their position in half from two weeks ago this was just reported this past Friday at 4 o’clock

0 · Reply

beachsidefreddy Jul. 14 at 2:56 PM

$LUNG someone thinks with a pretty big bet for this stock that this Friday it’s gonna be over $2.50

0 · Reply

Layne_Thomas_Staley Jul. 13 at 4:14 PM

$LUNG $

1 · Reply

beachsidefreddy Jul. 13 at 3:59 PM

$LUNG AERISEAL OR TAKEOVER COMING

0 · Reply

beachsidefreddy Jul. 13 at 3:02 PM

$LUNG SHORTS COVERED 1.2 MILLION SHARES IN LAST READ FROM NAZ!!

1 · Reply

beachsidefreddy Jul. 9 at 10:08 PM

$LUNG on the 17th expiration there is a big OI on $2.50 calls

2 · Reply

beachsidefreddy Jul. 9 at 4:17 PM

$LUNG let the games begin

0 · Reply

beachsidefreddy Jul. 9 at 1:38 PM

$LUNG either one of two things are gonna happen shortly either AERISEAL or takeover

0 · Reply

beachsidefreddy Jul. 9 at 11:30 AM

$LUNG shorts returned highest number yet AERISEAL COMING VERY SOON

0 · Reply

beachsidefreddy Jul. 8 at 2:26 PM

$LUNG all this bullshit for the last half hour was to get that huge bid filled at 1:48

0 · Reply

beachsidefreddy Jul. 8 at 1:44 PM

$LUNG for 10th time I ask: WHY IS GOLDMAN SACHS ON THE BOX HERE FOR WITH THE STOCK SELLING FOR $1.50 THERE’S A DEAL IN THE WORKS

0 · Reply

beachsidefreddy Jul. 8 at 1:31 PM

$LUNG MONSTER BID

0 · Reply

beachsidefreddy Jul. 7 at 2:05 PM

$LUNG the shorts would never allow this to happen unless they were worried about a major event coming

0 · Reply

beachsidefreddy Jul. 7 at 2:31 AM

$LUNG AERISEAL

0 · Reply

beachsidefreddy Jul. 6 at 1:20 PM

$LUNG AERISEAL NEWS HAS TO HIT SOON

1 · Reply

beachsidefreddy Jul. 6 at 11:49 AM

$LUNG RUNNER!!!!!!!!!

0 · Reply

topstockalerts Jul. 1 at 11:03 PM

$LUNG the stock seems comfortable exploring higher prices.

0 · Reply

HarmonyPioneer67 Jul. 1 at 9:36 PM

$LUNG where is everyone?

1 · Reply

beachsidefreddy Jul. 1 at 7:50 PM

$LUNG called it own huge!!

0 · Reply

beachsidefreddy Jul. 1 at 1:37 PM

$LUNG they wanna own the stock showing in Q3 with the aeriseal news coming and the Russell behind us

0 · Reply

beachsidefreddy Jul. 1 at 12:47 PM

$LUNG not bearish at all HUGE BULLISH

0 · Reply

beachsidefreddy Jun. 29 at 9:38 PM

$LUNG huge OI in July 17 $2.50 calls considering they dont trade almost ever in options on stock

0 · Reply

Market Cap	61.67M
Revenue (ttm)	90.50M
Net Income (ttm)	-54.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-59.67%
Debt to Equity Ratio	0.81

Volume	191,600
Avg Vol	489,174
Day's Range	N/A - N/A
Shares Out	42.24M
Stochastic %K	59%
Beta	0.30
Analysts	Sell
Price Target	$3.40